MUSC: Promising new option for pancreatic cancer
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Mon, 14 September 2026
What it is about
Craig LockhartHollings Cancer CenterDuke Cancer InstituteDrug AdministrationAccess ProgramOncology CenterNational CancerShellAmerican Society For Clinical OncologyAmericanCharleston, South Carolina, United StatesSouth Carolina, United States
Who published it, and when
How it spread - 1 original report
Mon, 14 September 2026
1 report- postandcourier.com14:15first to report
Thunderous applause at this year’s American Society for Clinical Oncology (ASCO) meeting in May — hardly the typical reaction at a medical conference — greeted the announcement of results of a phase III clinical trial for a new drug to treat metastatic pancreatic cancer.